Oncology
- Ref-No. Technology
-
01-00986
Non-invasive and high-throughput monitoring of exon-specific isoform expression
-
01-00988
INSPECT - Intron encoded reporter transcripts for minimally invasive monitoring of coding and non-coding RNAs
-
01-01045
Ex vivo method for determination of oxidative stress and diagnosis of ferroptosis-associated diseases
-
01-01080
Drug combinations to overcome therapy resistance in cancer
-
03-00397
Plasma cell-specific antibodies targeting BCMA for the treatment of multiple myeloma and autoimmune diseases
-
03-00413
Improved Sleeping Beauty Transposon System for gene therapy: SB100X/pT4
-
03-00430
Selective Inhibitors of Genotoxic Stress Induced IKK/NFκB Pathways for Cancer Therapy
-
03-00539
Sleeping Beauty transposase variants with increased safety due to reduced half-life
-
03-00553
Human TCR constructs for adoptive cell therapy of cancer
- 14-00013 MAdL monoclonal antibody: A novel, highly specific and sensitive biomarker for adenocarcinomas of the lung
-
14-00135
Epigenetic detection of early-stage non-small cell lung cancer in blood
-
14-00176
Efficient, adjuvant-free mucosal vaccination via IgA feedback loop
-
15-00502
Predicting the therapeutic effect of compositions containing BH3 mimetics
-
15-00514
LS-COAT – an exceptionally efficient tumor vaccination approach
-
15-00604
Novel Diagnostic Marker For Early Detection Of Bladder Cancer
- 15-00612 TCR-agnostic identification of tumor-specific T cells for cancer diagnostics and therapy
-
15-00751
Prediction of L-Asparaginase resistance in tumor therapy
- 22-00017 Functional IFN-gamma memory in CD4+ T cells: Method for improved T cell therapy and disease monitoring in autoimmune diseases
-
32-00059
T-cell therapy of MYD88L265P-dependent B-cell lymphoma
-
32-00076
Next generation allogeneic CAR-NK cell platform for treatment of malignant diseases
-
32-00099
A novel immuno-oncology approach for induction and massive amplification of antigen-specific cytotoxic CD8+ T-cells
-
32-00124
CD3-CAR NK-92 cell-mediated TCR+ depletion
-
32-00128
Method for Assessing Out-of-Specification (OOS) CAR T-Cell Products and Predicting Patient Response
-
32-00164
The CXCR3alt-CXCL11 chemokine system for therapeutic use in solid cancer
-
33-00002
Rapid, simultaneous and non-destructive blood diagnostics using a multi-omics NMR platform
-
42-00076
NICHE-CAR-T: NR2F6 Immune Checkpoint Harnessing to Enhance CAR-T efficacy
-
42-00086
FAP-targeted dual imaging for guided cancer surgery
-
43-00013
CRISPR StAR: facilitating high resolution genetic screening in complex in vivo models
-
43-00016
SARSeq: Multiplexed, parallel detection of SARS-CoV2 variants and other viruses in high-throughput
-
43-00016
Two-Dimensional Redundant Dual Barcoding for Ultra-High-Throughput, Error-Resilient Nucleic Acid Analysis
-
43-00026
Efficient multiplex cryo-embedding method for cost-efficient, high-throughput tissue analysis
-
43-00034
Biomarker set for early and non-invasive diagnosis and differentiation of renal cell carcinomas
